Ikena Oncology Inc (IKNA): $196.9M in cash, cash equivalents, and m...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	14
Posts	726
Boards Moderated	0
Alias Born	05/13/2016

herbied47

Re: None

Friday, 11/10/2023 12:22:34 PM

Friday, November 10, 2023 12:22:34 PM

$196.9M in cash, cash equivalents, and marketable securities, which it said would support operations well into 2026. $5.40 a share in cash
Market cap 37 million as of now. Price targets still between $8 and $11. Lots of upcoming catalyst Bullish

Bullish

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent IKNA News

Ikena Oncology to Present at the Stifel 2024 Virtual Targeted Oncology Forum • GlobeNewswire Inc. • 04/10/2024 12:00:00 PM
Ikena Oncology Reports Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 03/12/2024 12:00:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:05:21 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:01:16 PM
Ikena Oncology to Participate in TD Cowen 44th Annual Health Care Conference • GlobeNewswire Inc. • 02/27/2024 01:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 09:29:08 PM
Ikena Oncology Appoints Caroline Germa, M.D. as Chief Medical Officer • GlobeNewswire Inc. • 02/21/2024 09:15:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 10:15:05 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 10:07:47 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/18/2024 09:26:52 PM
Ikena Oncology Outlines Key Priorities and Provides Corporate Updates • GlobeNewswire Inc. • 01/18/2024 09:05:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 12:30:26 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 12:09:22 PM
Ikena Oncology Shares Initial Positive and Differentiated Dose Escalation Data from IK-930 Phase I Trial and Reports Third Quarter 2023 Financial Results • GlobeNewswire Inc. • 11/09/2023 12:00:00 PM
Ikena Oncology to Present at Multiple November 2023 Investor Conferences • GlobeNewswire Inc. • 11/07/2023 01:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 09:10:53 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 09/25/2023 08:05:20 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 09/15/2023 08:05:57 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/12/2023 08:11:09 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/11/2023 04:15:23 AM
Ikena Oncology to Participate in September 2023 Investor Conferences • GlobeNewswire Inc. • 09/05/2023 12:00:00 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/18/2023 08:02:27 PM
Ikena Oncology Reports Second Quarter 2023 Financial Results and Corporate Update • GlobeNewswire Inc. • 08/10/2023 12:00:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 11:00:57 AM

More IKNA News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover